《IAPAC改善HIV感染者接受并持續(xù)獲得治療以及對(duì)抗逆轉(zhuǎn)錄病毒治療依從性的指南》內(nèi)容預(yù)覽

ntry into and Retention in HIV Medical Care
1. Systematic monitoring of successful entry into HIV care is recommended for all individuals diagnosed with HIV (IIA).
2. Systematic monitoring of retention in HIV care is recommended for all patients (IIA).
3. Brief, strengths-based case management for individuals with a new HIV diagnosis is recommended (IIB).
4. Intensive outreach for individuals not engaged in medical care within 6 months of a new HIV diagnosis may be considered (IIIC).
5. Use of peer or paraprofessional patient navigators may be considered (IIIC).Monitoring Antiretroviral Therapy Adherence
6. Self-reported adherence should be obtained routinely in all patients (IIA).
7. Pharmacy refill data are recommended for adherence monitoring when medication refills are not automatically sent to patients (IIB).
8. Drug concentrations in biological samples are not routinely recommended (IIIC).
9. Pill counts performed by staff or patients are not routinely recommended (IIIC).
10. Electronic drug monitors are not routinely recommended for clinical use (IC).Antiretroviral Strategies
11. Among regimens of similar efficacy and tolerability, once-daily regimens are recommended for treatment-naive patients beginning ART (IIB).
12. Switching treatment-experienced patients receiving complex or poorly tolerated regimens to once-daily regimens is recommended, given regimens withequivalent efficacy (IIIB).
13. Among regimens of equal efficacy and safety, fixed-dose combinations are recommended to decrease pill burden (IIIB).

點(diǎn)擊下載完整版《IAPAC改善HIV感染者接受并持續(xù)獲得治療以及對(duì)抗逆轉(zhuǎn)錄病毒治療依從性的指南》